Figures
Abstract
Mutations in MINDBOMB 1 (MIB1), encoding an E3 ubiquitin ligase of the NOTCH signaling pathway, cause left ventricular noncompaction cardiomyopathy (LVNC) in mice and humans, increasing the risk of arrhythmia and left ventricular dysfunction. This study aimed to investigate the effect of MIB1 mutations on cardiac electrical activity. We examined male Mib1flox;Tnnt2Cre mice, a disease model of LVNC, and wildtype littermates on the C57BL/6J genetic background. Our results demonstrate that the gap-junction protein connexin43 was delocalized from the intercalated disks to the lateral long axis of Mib1flox;Tnnt2Cre cardiomyocytes. Cardiomyocyte electrophysiology revealed an increase in the Na (INa) peak density at potentials between -50 and -30 mV in Mib1flox;Tnnt2Cre mice, with no changes in INa activation or inactivation kinetics. Mib1flox;Tnnt2Cre cardiomyocytes also showed decreases in outward K+ peak currents and currents at the end of depolarizing pulses at potentials ≥−10 mV and ≥−20 mV, respectively, and this was accompanied by a lower charge density at ≥−20 mV. Action potential duration was increased in Mib1flox;Tnnt2Cre cardiomyocytes. The cardiac stress, induced by swimming endurance training or β-adrenergic stimulation with isoproterenol, increases QTc duration in Mib1flox;Tnnt2Cre mice, accompanied by a decrease in T-wave amplitude and area. Swimming endurance training decreased heart rate in wildtype and Mib1flox;Tnnt2Cre mice but was unaffected by long-term isoproterenol treatment. These mouse findings are in agreement with an increased QTc duration found in LVNC patients carrying MIB1 mutations. These results provide insight into the outcomes of LVNC and relate its pathogenicity to impaired ventricular repolarization.
Citation: Fernandes VS, Caballero R, Siguero-Álvarez M, Papoutsi T, Gimeno-Blanes JR, Delpón E, et al. (2025) Cardiac electrical abnormalities in a mouse model of left ventricular non-compaction cardiomyopathy. PLoS One 20(5): e0314840. https://doi.org/10.1371/journal.pone.0314840
Editor: Pan Li, Institute for Basic Science, KOREA, REPUBLIC OF
Received: November 22, 2024; Accepted: March 5, 2025; Published: May 7, 2025
Copyright: © 2025 Fernandes et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files
Funding: This study was supported by grants PID2022-136942OB-I00, PID2019-104776RB-I00 and CB16/11/00399 (CIBER CV) from MICIU/AEI/10.13039/501100011033, a grant from the Fundación BBVA (BIO14_298), and grants for Translational Research in Cardiology (SEC/FEC-INV-TRL 20/009) from the Spanish Society of Cardiology to J.L.d.l.P. In addition, E.D and R.C were supported by grants PID2022-118694-RB-I00, CB16/11/00303 (CIBER CV), and Comunidad de Madrid (S2017/BMD-3738; European Structural and Investment Funds). The cost of this publication was supported in part with funds from the European Regional Development Fund. The CNIC is supported by the ISCIII, the MCIN and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S) financed by MCIN/AEI /10.13039/501100011033.
Competing interests: The authors have declared no competing interests exist.
Introduction
Left ventricular non-compaction (LVNC) is a heterogeneous cardiomyopathy with a poorly understood etiology and is believed to result from in utero alteration of ventricular chamber development [1], although isolated cases of acquired and potentially reversible LVNC have also been reported [2]. LVNC is characterized by prominent trabeculations, deep endocardial recesses in the ventricular wall, and a thin compact myocardium layer [3]. The clinical consequences of these structural abnormalities vary, ranging from mild effects with normal heart function to congestive heart failure, cardiac conduction abnormalities, ventricular tachyarrhythmia, and sudden cardiac death [3–6]. Ventricular arrhythmia and myocardial dysfunction in LVNC patients are predictors of premature death [6].
LVNC exhibits genetic heterogeneity, primarily following an autosomal-dominant inheritance pattern [7], and is strongly associated with sarcomere gene mutations, especially in MYH7 [7,8]. Additional mutations linked to LVNC involve genes encoding scaffold and nuclear proteins [8,9]. Its proposed developmental origin suggests that genetic alterations impacting signaling pathways and transcription factors regulating cardiovascular development play a key role [10–13]. A key mediator of cell fate specification and tissue patterning in metazoans is the highly conserved signaling pathway NOTCH [14,15], whose disruption in humans leads to developmental abnormalities affecting the heart and vessels [16–19]. Functional studies in mice have shown that NOTCH is crucial for the endocardium-to-myocardium signaling that governs the development of the cardiac valves and ventricular chambers and have shed light on the disease mechanisms associated with NOTCH dysfunction [reviewed in [20,21]]. We previously showed that LVNC in mice and humans can be caused by mutations in the gene encoding the ubiquitin ligase MINDBOMB1 (MIB1) [22], which is required for NOTCH ligand endocytosis and signaling activation [23]. Myocardium-specific inactivation of Mib1 in mice disrupts ventricular maturation and patterning, so that persistent trabeculae and thinner ventricular walls are found in the adult heart, severely impairing its function [22,24,25]. LVNC families carrying disease-co-segregating germline MIB1 mutations have large persistent trabeculae and severely reduced ventricular function [22]. LVNC is usually associated with abnormal electrocardiographic (ECG) patterns, such as intraventricular conduction delays, voltage signs of left ventricular hypertrophy, left axis deviation, repolarization abnormalities, and QTc prolongation [26,27]. The aim of this study was to investigate the mechanisms underlying ECG alterations associated with LVNC, utilizing a previously described mouse model of this condition.
Materials and methods
Animal studies
Animal studies were approved by the CNIC Animal Experimentation Ethics Committee, the Complutense University of Madrid and the Community of Madrid (Ref. PROEX 155.7/20). All animal procedures conformed to EU Directive 2010/63EU and Recommendation 2007/526/EC regarding the protection of animals used for experimental and other scientific purposes, enacted in Spanish law under Real Decreto 1201/2005. We used 20-week-old male Mib1flox/flox;Tnnt2Cre/+ (hereafter Mib1flox;Tnnt2Cre) mutants and their respective wildtype littermates Mib1flox/flox;Tnnt2 +/+ (WT), congenic on the C57BL/6J background. Mice were housed in wire-bottomed cages in a temperature-controlled room (22±0.8°C) with a 12 h light–dark cycle and a relative humidity of 55±10%. Mice had free access to food and water. Mice were euthanized following institutional and national ethical guidelines using CO₂ inhalation followed by cervical dislocation to ensure humane sacrifice.
Mouse electrocardiography
ECGs were recorded in anesthetized mice as previously described [28]. Briefly, mice were placed in a supine position on a temperature-controlled surface and were anesthetized with 1.5–2% isoflurane. Four needle electrodes were subcutaneously inserted into the limbs. ECG recordings were acquired with a MP36R Biopac System and analyzed offline with LabChart7 (AD Instruments, Australia). A high-pass filter setting of 0.5 Hz was applied to remove the baseline wander using a bidirectional filtering strategy. The PR interval was measured from the beginning of the positive deflection of the P wave to the peak of the R wave, the QRS interval was measured from the start of the Q wave to the point where the S wave crosses the isoelectric line, and the QT interval was measured from the start of the Q wave to the point where the T wave reaches the 90% of the decline [28]. All these intervals were calculated as the mean of ~ 450 ECG measurements, and QTc duration was calculated by considering the correction for RR intervals according to Bazett’s formula for murine ECG [29]:
The T wave amplitude was measured as the T peak in mV and the area of the T wave was measured as the area under the curve averaging 5 T waves areas from each animal.
Human electrocardiography
ECGs from patients with LVNC were obtained in accordance with human subject guidelines and following the approved protocol by the Hospital Universitario Virgen de la Arrixaca, Murcia, Spain. All patients provided written informed consent. Human ECG measurements were recorded using standard methods in patients carrying the MIB1 mutations and in healthy relatives to assess differences in ventricular repolarization. Data were accessed for research purposes in September 2023. ECG of subject V943F-2 was taken at clinical stable situation on medication (ACE inhibitor and spironolactone) during admission. Subject R530X-1 and R530X-2 were on betablockers at the time of the ECG recording. All patients (apart from subject V943F-2) and all the controls were evaluated in an outpatient clinic area. ECG was performed after at least 3 min in supine position. Controls were off medications.
Lead II and precordial V5 traces, commonly used to diagnose repolarization abnormalities3, were selected to assess temporal and morphological differences between patients and healthy relatives. QTc duration was calculated by considering the correction for RR intervals according to Bazett’s. Moreover, we have calculated the QTc values using the Hodges formula, QTc = QT + 1.75.(HR-60). The following short-term QT variability markers were calculated according to the formulas listed below: QT variance (QTvar), standard deviation of the QT intervals (SDqt), short-term variability of the QT intervals (STVqt), QT variance normalized to mean QT interval (QTVN), QT variability index (QTVIHR), and the root mean square of the successive QT interval differences (RMSSDqt).
Mouse endurance training
The endurance training protocol was as described previously [30]. Briefly, mice were first acclimatized to water by being placed in glass container (60×30×45 cm) with shallow water at a constant warm temperature (~30ºC) to minimize environmental stress. The endurance training took place during the dark phase of the light-dark cycle, corresponding to peak mouse activity. After the adaption period, the mice gained swimming experience over 2 weeks, with the swimming duration increasing by 5 min per day until reaching 45 min at the end of the second week. Over the next 3 weeks (weeks 3–6), the swimming duration increased by 15 min each week and was then maintained at 90 min per day during weeks 6–8 (Table 1).
Isoproterenol treatment
Isoproterenol is a synthetic non-selective β1- and β2-adrenergic receptor agonist that is widely used to measure the ability of the heart to respond to stress stimuli [31]. WT and Mib1flox;Tnnt2Cre mice received twice-weekly i.p. bolus injections of isoproterenol (3 mg/kg) over a period of 4 weeks. ECGs were recorded at baseline (before the first isoproterenol injection), and at the end of the isoproterenol administration protocol. Data were recorded and analyzed as described in §Mouse electrocardiography.
Blood pressure measurements
Blood pressure was measured with an automated tail-cuff device (Visitech System BP2000, NC). Mice received training for one week to adapt to the system. Weekly measurements were then taken at the same time of day. The first 10 measurements on each measurement day were rejected, and results are presented as the mean of the last 10 measurements.
Single cell electrophysiology
Recording techniques: Single ventricular myocytes were isolated from cardiac tissue by enzymatic dissociation with collagenase type II (Worthington Biochemical Corporation Lakewood, NJ, USA) and protease (type XIV, Sigma Chemical Co. London, UK) [32,33]. Mice were heparinized (5000 U/kg i.p.) and anesthetized with ketamine (150 mg/kg i.p.) and xylazine (10 mg/kg i.p.). Currents were recorded at room temperature (21–23ºC) by whole-cell patch clamping using an Axopatch-200B patch clamp amplifier (Molecular Devices, USA) [32,33]. Recording pipettes were pulled from 1.0 mm o.d. borosilicate capillary tubes (GD1, Narishige Co., Ltd, Japan) using a programmable patch micropipette puller (Model P-2000 Brown-Flaming, Sutter Instruments Co., USA) and were heat-polished with a microforge (Model MF-83, Narishige). For measurements of micropipette resistance, the micropipette was filled with the internal solution and immersed in the external solution. Micropipette resistance was kept below 1.5 MΩ for the sodium currents (INa), below 3.5 MΩ for other currents, or above 7 MΩ for measurement of action potentials (AP). In all experiments, series resistance was compensated manually by using the series resistance compensation unit of the Axopatch amplifier, and ≥80% compensation was achieved. Uncompensated access resistance was 2.2±1.8 MΩ (n=133). Thus, considering the myocyte capacitance, we expected no significant voltage errors (<5 mV) due to series resistance with the micropipettes used. To minimize the contribution of time-dependent shifts in channel availability during INa recordings, all data were collected 20 min after establishing the whole-cell configuration. Under these conditions, current amplitudes and voltage dependence of activation and inactivation were stable during recordings [32,33]. The current recordings were sampled at 4 kHz (except for INa, which was sampled at 50 kHz), filtered at half the sampling frequency, and stored on a computer hard disk for subsequent analysis.
Solutions: For recordings of INa, the external solution contained (mM): NaCl 4, MgCl2 1.0, CaCl2 1.0, CdCl2 1.0, CsCl1 33.5, HEPES 20, and glucose 11 (pH=7.35 with CsOH). Recording pipettes were filled with an internal solution containing (mM): NaF 10, CsF 110, CsCl 20, HEPES 10, and EGTA 10 (pH 7.35 with CsOH). The L-type Ca+ currents (ICaL) were recorded in myocytes superfused with an external solution containing (mM): tetraethylammonium 137, CaCl2 1, MgCl2 0.5, HEPES 10, and glucose 10 (pH=7.4 with CsOH). The internal solution contained (mM): CsCl 125, TEA-Cl 20, MgATP 5, phosphocreatine 3.6, HEPES 10, and EGTA 10 (pH=7.2 with CsOH). For recordings of inward rectifier currents (IK1), the external solution contained (mM): NaCl 140, 4 mM KCl, CaCl2 1, MgCl2 1, HEPES 10, 4-aminopyridine 2, glucose 10, and nifedipine 1 µM, atropine 0.1 µM, and glibenclamide 10 µM (pH=7.4 with NaOH). Recording pipettes were filled with an internal solution containing (mM): K-aspartate 80, KCl 42, KH2PO4 10, MgATP 5, phosphocreatine 3, HEPES 5, and EGTA 5 (pH 7.2 with KOH). For outward K+ currents, the external and internal solutions were identical to those used for IK1 recordings, but without 4-aminopyridine in the external solution. For AP recordings, the external solution contained (mM): NaCl 136, KCl 4, CaCl2 1.8, MgCl2 1, HEPES 10, and glucose 10 (pH 7.4 with NaOH). The internal solution contained (mM): K-aspartate 80, KCl 42, KH2PO4 10, MgATP 5, phosphocreatine 3, HEPES 5, and EGTA 5 (pH=7.2 with KOH). The currents were not corrected for the liquid junction potentials.
Pulse protocols: To construct the current-voltage relationships for INa, we applied 50-ms pulses in 5 mV increments from −120 mV to potentials between −100 and +30 mV. INa amplitude was measured as the difference between the peak transient current and the current at the end of the pulses and was normalized to cell capacitance to obtain the density. To construct the inactivation curves, INa was recorded by applying 500-ms pulses from −120 mV to potentials between −140 and -20 mV in 10 mV increments followed by a test pulse to −20 mV. To analyze the recovery from inactivation of INa, we applied two 50-ms pulses (P1 and P2) from –120 to −40 mV at increasing coupling intervals (0.05–500 ms). Reactivation kinetics were measured by fitting a mono exponential function to the data. The late component of INa (INaL) was recorded by applying 500-ms pulses from –120 to –40 mV, and was measured as the percentage of the peak INa recorded. To construct current-voltage relationships for ICaL, we applied 500-ms pulses in 5 mV increments from –80 mV to potentials between –40 and +50 mV. The INa was inactivated by applying a 50-ms prepulse to –30 mV. The L-type calcium current (ICaL) was measured as the difference between the peak current and the current at the end of the pulses and was normalized to the cell capacitance to calculate the ICaL density. Inactivation curves for ICaL were obtained by applying a 500-ms conditioning pulse from –70 mV to potentials between –90 and +50 mV, followed by a test pulse to 0 mV. Conductance-voltage curves for INa and ICaL were constructed by plotting the normalized conductance as a function of the membrane potential. The conductance was estimated for each experiment using the equation listed below: G is the conductance at the test potential Vm, I represent the peak maximum current at Vm, and Erev is the reversal potential.
To determine the Erev, INa and ICaL density-voltage relationships obtained in each experiment were fitted to a function of the form below: where I is the peak current elicited at the test potential Vm, Gmax is the maximum conductance, and k is the slope factor.
The protocol to record IK1 consisted of 250-ms steps imposed in 10 mV increments from –80 mV to potentials ranging –120 and –30 mV. IK1 was always measured at the end of the 250-ms pulses. Current–voltage relationships for outward K+ currents were constructed by applying 500-ms pulses in 10 mV increments from –80 mV to potentials ranging –80 and +50 mV. Peak outward K+ currents were measured as the difference of the peak and the current at the end of the pulse, while sustained outward K+ currents were measured at the end of the pulses. The charge was estimated from the integral of the current traces comprising the area between the peak and the current at the end of the 500-ms pulse. APs elicited by depolarizing-current pulses of 2 ms in duration at 1.5–2 times the current threshold at a frequency if 1Hz were recorded in the current-clamp configuration of the patch-clamp technique.
Immunohistochemistry
Hearts from WT and Mib1flox;Tnnt2Cre mice were fixed overnight at 4ºC in 4% paraformaldehyde in phosphate saline buffer (PBS), pH 7.4. Hearts were then dehydrated through a graded series of ethanol concentrations. The tissue was then embedded in paraffin, and longitudinal 5 μm sections were cut on a microtome. The sections were dewaxed and cleaned with PBS. Antigens were retrieved by heating the sections in sodium citrate buffer (10 mM). Endogenous biotin was blocked using an avidin/biotin kit (Vector Laboratories), and non-specific IgG binding sites were blocked with histoblock solution (5% goat serum, 3% BSA 20 mM MgCl2, and 0.3% Tween 20). Sections were then incubated overnight at 4ºC with anti-CX43 (1:200, Sigma-Aldrich) and anti-N-cadherin (1:100, Invitrogen, Life Technologies). After several washes in PBS, samples were incubated for 2h with biotinylated anti-rabbit IgG (1:200, Vector Laboratories), washed again, and incubated for 2h at room temperature with TRITC-coupled extravidin and Alexa Fluor 488 (1:200, Thermo Fisher Scientific). Cell membranes were stained with wheat germ agglutinin (WGA Rhodamine, 1:100, Vector Laboratories or Alexa-Fluor 488-conjugated WGA, 1:200, Thermo Fisher). Cell nuclei were stained with DAPI (1:1000, Sigma-Aldrich). Samples were visualized using a Zeiss 700 confocal microscope. All image analyses were performed using Fiji (ImageJ, NIH). Raw immunohistochemically fluorescently-labeled mouse heart sections were analyzed to accurately quantify Cx43 localization at the intercalated discs. Briefly, the percentage area occupied by the Cx43 signal was determined relative to the area occupied by the N-Cadherin signal. To assess the distribution of Cx43 relative to the lateral membrane, we quantified the percentage area of the Cx43 signal that co-localized with the WGA signal and compared it to the area of the Cx43 signal within the ICD. The ratio (lateral Cx43 area/ ICD Cx43 area) was then calculated to evaluate the degree of Cx43 lateralization and expressed as a percentage. For immunofluorescence of ion channels, single ventricular myocytes were isolated from hearts by enzymatic dissociation (liberase blendzyme, Roche) as previously described [34]. Briefly, hearts were excised and retrogradely perfused at 37ºC for 6–8 min with a modified tyrode solution (113 mM NaCl, 4.7 mM KCl, 0.6 mM KH2PO4, 0.6 mM Na2HPO4, 1.2 mM MgSO4-7H2O, 0.032 mM Phenol red, 12 mM NaHCO3, 10 mM KHCO3, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonicacid, and 30 mM taurine, pH 7.4). Next, hearts were perfused with the same buffer containing 0.1 mg/ml liberase (Roche) until the complete digestion was achieved. The ventricles were then mechanically dissociated and single cells were transferred to a test tube containing the same solution but with the enzyme replaced with bovine calf serum (BCS, 5%) and progressive concentration of CaCl2 to reach a final concentration of 1 mM. Cells were fixed in 4% paraformaldehyde in PBS for 30 min at room temperature and then washed three times for 5 min with PBS containing 2% BSA. The cells were then permeabilized with 1% Triton X-100 at 25 °C for 10 min. Non-specific IgG binding sites were blocked with histoblock solution. Cells were rinsed repeatedly and incubated overnight at 4ºC with the primary antibodies anti-KV4.2 (1:200, Alomone labs, Israel), anti-KV4.3 (1:200, Alomone labs, Israel), anti-NaV1.5 (1:200, Alomone labs, Israel), and anti-α-actinin (1:200, Sigma). Samples were visualized with a Zeiss 700 confocal microscope. All image analysis were performed using Fiji (ImageJ, NIH).
Picrosirius red histology
Heart sections were obtained as described in immunohistochemistry section. Briefly, the nuclei were stained with Weigert’s haematoxilin for 8 min, and then the slides were washed for 10 min in running tap water. Next, slides were stained in picrosirius red solution for 1 h and then washed in two changes of acidified water. The slides were then dehydrated in 3 changes of 100% ethanol and cleared in xylene. The slides were mounted in a resinous medium. All images were analyzed using Fiji (ImageJ, NIH) to determine collagen area and data were collected from 3 section per animal. Fibrosis was quantified by analyzing the section area occupied by Picro-Sirius Red (PSR)-positive fibers. The area occupied by PSR-positive fibers was quantified using Fiji (ImageJ, NIH) to determine collagen area and data were collected from 3 section per animal. This was performed by thresholding the color intensity corresponding to PSR-positive fibers, followed by normalization to the total area of the tissue section. Fibrosis was then expressed as percentage.
Western blot
Hearts from WT and Mib1flox;Tnnt2Cre mice were obtained immediately harvested after mice were sacrificed and frozen in isopentane, and stored at -80°C to carry out biochemical studies. Protein samples (20–40 µg) from each frozen tissue were denatured and resolved using SDS-PAGE (sodium dodecyl-sulfate polyacrylamide gel electrophoresis). The separated proteins were transferred to a PVDF membrane (GE Healthcare, UK). To block non-specific binding, the membranes were incubated for one hour at room temperature in TBST containing 5% nonfat dried milk. Following this, the membranes were incubated with primary antibodies: anti-KV4.2 (1:200, Alomone Labs, Israel), anti-KV4.3 (1:400, Alomone Labs, Israel), and anti-NaV1.5 (1:100, Alomone Labs, Israel). The membranes were then incubated with HRP-conjugated secondary antibodies (1:5000; GE Healthcare, UK) for 2 hours at room temperature. The peroxidase activity was detected using an Enhanced Chemiluminescence (ECL) Kit (GE Healthcare, Buckinghamshire, UK), and the signals were visualized with a Gel-Doc system using Quantity One 4.5.1 software (Bio-Rad, Hercules, USA). For loading normalization, stain-free technology was applied (Bio-Rad, Spain), and images of both the target proteins and the total protein were analyzed using ImageLab software (version 6.0.0, Bio-Rad, Hercules, USA) to determine the intensity per mm² of each band and lane. The relative protein levels were normalized to the intensity of GAPDH loading blots.
Statistical analysis
Results are presented as the mean±SD n animals/subjects or mean±SEM of n experiments as indicated. In all analyses, n represents the number of biological replicates, ensuring that statistical comparisons reflect biological variability rather than intra-sample variation. Differences were analyzed by parametric unpaired two-tailed t-test or the non-parametric analog Mann–Whitney or Wilcoxon’s test for comparisons between two groups and by ANOVA followed by the Tukey or Bonferroni post-hoc test for multiple comparisons. To consider repeated sample assessments, data were analyzed with multilevel mixed-effects models. Comparisons between categorical variables were by the Fisher exact test. Differences were considered statistically significant at p<0.05.
Results
Mutations in the human MIB1 homolog are associated with long QT prolongation
MIB1 mutations were previously reported in two LVNC families [22]. ECG comparisons between affected individuals carrying the MIB1V943F or MIB1R530X mutations and their healthy relatives (S1 Fig) showed no significant differences in heart rate, PR interval, QRS duration, or RR interval (Fig 1A,B; Table 1).
(A) PR interval measurements in healthy family members (control) and LVNC patients. (B) QRS measurements in healthy family members (control) and LVNC patients. (C) QTc measurements using the Bazzet formula for healthy family members (control) and LVNC patients. (D-I) Short-term QT variability markers predicting arrhythmias and sudden cardiac death in healthy family members (control) and LVNC patients: (D) QT variance, (E) standard deviation of QT intervals, (F) short-term beat-to-beat temporal QT variability, (G) QT variance normalized to mean QT interval, (H) QT variability index (log ratio of normalized QT variance to normalized heart rate variance), and (I) root mean square of successive QT interval differences. Insets show QT variability markers for LVNC patients with V943F or R530X MIB1 mutations. Statistical significance was determined by the Mann–Whitney test. Results are mean±SD of 4 patients. ns, non-significant. *P < 0.05 vs control.
However, those with MIB1 mutations exhibited longer corrected QT intervals (QTc) compared to healthy relatives ((Fig 1C; Table 1, 493.5±9.1 ms vs 430.8±27.5 ms). Notably, some mutation carriers displayed left axis deviation (Table 1). Analysis of QT variability markers revealed elevated values in MIB1 mutation carriers, indicating an increased risk of ventricular arrhythmias (Fig 1 D-I and Table 2). These results suggest that individuals carrying MIB1 mutations have increased markers of QT variability and thus an elevated risk of ventricular arrhythmias.
ECG abnormalities and prolonged action potential duration in Mib1flox;Tnnt2Cre mice
We investigated the electrocardiographic phenotype of Mib1flox;Tnnt2Cre mice, a model of LVNC due to impaired NOTCH signaling [22], to compare it with patients carrying MIB1 mutations. While these mice showed reduced ejection fraction at 6 months [22], there were no differences in systolic or diastolic pressure between wild type (WT) and mutant mice, both at baseline and after swimming endurance training (S2A,B Fig.). Heart weight/tibial ratio was also similar between groups (S2C Fig.). Baseline measurements of heart rate (Fig 2A,B,C), PQ interval (Fig 2D,G), QRS duration (Fig 2E,H), and QTc90 interval (Fig 2F,I), revealed no differences between WT and Mib1flox;Tnnt2Cre mice. An 8-week swimming regimen (Table 3), during which both WT and Mib1flox;Tnnt2Cre mice swam similar distances
(A) ECG recording showing measured intervals. (B, C) Mean heart rate (bpm) of isoflurane-anesthetized WT and Mib1flox;Tnnt2Cre mice before and after swimming endurance training (B) or at the end of the isoproterenol protocol (C). (D) PQ, (E) QRS, and (F) QTc90 duration measured before and after swimming endurance training. (G) PQ, (H) QRS, and (I) QTc90 duration measured before and at the end of the isoproterenol protocol. Statistical significance was determined by ANOVA with Tukey post-hoc test. *P < 0.05 vs WT. Results are mean±SD of 6-9 animals.
(S2D Fig 2 and S1,2 Videos) resulted in a slight but significant decrease in heart rate in WT mice, with no difference observed between WT and Mib1flox;Tnnt2Cre groups (Fig 2B). One WT mouse and four Mib1flox;Tnnt2Cre mice died during the training (S2E Fig.). Additionally, swimming endurance training did not significantly affect the PQ interval (Fig 2D). However, Mib1flox;Tnnt2Cre mutants exhibited increased QRS (Fig 2E) and QTc90 intervals (Fig 2F) compared to WT, indicating exercise-induced conduction abnormalities.
Chronic isoproterenol treatment showed no differences in heart rate (Fig 2C), PQ interval (Fig 2G) or QRS duration (Fig 2H) between genotypes, but QTc90 was significantly prolonged in Mib1flox;Tnnt2Cre mutants (Fig 2I). T-wave amplitude and area under the curve were comparable at baseline (Fig 3A,A’), but decreased significantly in Mib1flox;Tnnt2Cre mice after swimming (Fig 3B,B’,C,D), suggesting exercise-induced ventricular repolarization abnormalities. Next, we recorded action potentials (APs) from cardiomyocytes dissociated from Mib1flox;Tnnt2Cre mice, paced at 1 Hz (Fig 4A). We found no differences between genotypes in resting membrane potential (RMP, Fig 4B) or action potential amplitude (APA, Fig 4C). However, AP duration (APD) at 20% (APD20, Fig 4D), 50% (APD50, Fig 4E), and 90% (APD90, Fig 4F) repolarization was significantly prolonged in Mib1flox;Tnnt2Cre cardiomyocytes.
(A) Representative QRS complex and T-wave, with (A’) a close-up of the T-wave in WT and Mib1flox;Tnnt2Cre mice before the swimming protocol. (B) Representative QRS complex and T-wave, with (B’) a close-up of the T-wave after the swimming protocol, showing differences in T-wave morphology. (C and D) Summary data showing decreased T-wave amplitude (C) and area (D) in Mib1flox;Tnnt2Cre mice after training. Statistical significance was determined by unpaired two-tailed Student’s t-test.*P < 0.05 Results represent mean±SD of 7-5 animals per genotype.
Panels A-F show electrophysiological parameters in cardiomyocytes from WT (n=5) and Mib1flox;Tnnt2Cre mice (n=5). (A) Superimposed action potentials (APs), (B) resting membrane potential (RMP), (C) Action potential amplitude (APA), and (D-F) action potential duration (APD) measured at 20%, 50%, and 90% repolarization. Significant differences (*P<0.05 vs WT) in D-F were determined using unpaired two-tailed Student’s t-test, with non-parametric tests (two-sided Wilcoxon’s test) used for small sample sizes (n<15). Data were also analyzed using multilevel mixed-effects models to account for repeated sample assessments. Each bar represents the mean±SEM of 12 and 24 cardiomyocytes from five mice per genotype, with individual data point representing separate experiments.
Altered cell capacitance and increased peak INa density in Mib1flox;Tnnt2Cre mice
To assess changes in ionic currents underlying APs, we used patch-clamp recording techniques. Cardiomyocytes from Mib1flox;Tnnt2Cre mice exhibited significantly larger cell capacitance compared to WT (S3C Fig), confirmed by direct measurement of cardiomyocyte area using wheat germ agglutinin staining (S3A,B Fig.). We then recorded sodium currents (INa) in isolated cardiomyocytes from both genotypes. Fig 5A and B show INa traces and current-density voltage curve, respectively, revealing that Mib1flox;Tnnt2Cre cardiomyocytes had significantly higher peak INa density between -50 and-30 mV (Fig 5A,B), with no changes in current activation or inactivation kinetics (Table 4).
(A) INa traces from cardiomyocytes of WT and Mib1flox;Tnnt2Cre mice, with (B) mean peak INa density-voltage relationships shown (*P<0.05 vs WT). (C,D) Conductance-voltage and inactivation curves for INa, respectively, fitted with Boltzmann functions. Similar analyses for ICaL are shown in panels (E) to (H), with (F) depicting mean ICaL density-voltage relationships. Statistical analyses utilized unpaired two-tailed Student’s t-tests and, for smaller sample sizes, non-parametric tests (two-sided Wilcoxon’s test). Multilevel mixed-effects models were applied for repeated sample assessments. Each point (B-D and F-H) represents the mean±SEM of 17-13 WT and 9 Mib1flox;Tnnt2Cre cardiomyocytes from five mice per genotype.
The voltage dependence of peak INa activation and inactivation was similar in WT and Mib1flox;Tnnt2Cre cardiomyocytes (Fig 5C,D), with no significant differences in midpoint or slope values of conductance-voltage and inactivation curves (Table 4). S4 Fig. shows the time course of peak INa reactivation, which overlapped between both groups, indicating no change in reactivation kinetics in Mib1flox;Tnnt2Cre cardiomyocytes (Table 4). Additionally, late sodium current (INaL) measured by 500 ms pulses from -120 to -40 mV was also similar in WT and Mib1flox;Tnnt2Cre cardiomyocytes (S4B Fig.). Next, we examined potential differences in L-type calcium currents (ICaL). ICaL traces were recorded following a protocol shown in Fig 5E, revealing no difference in ICaL density between WT and Mib1flox;Tnnt2Cre cardiomyocytes across all tested potentials (Fig 5E,F). Activation and inactivation kinetics of ICaL were also similar between genotypes (Fig 5G, Table 4), although inactivation midpoint shifted to more depolarized potentials in Mib1flox;Tnnt2Cre cardiomyocytes (Fig 5H, Table 4).
Decreased peak and sustained outward K+ currents in Mib1flox;Tnnt2Cre mice
In mouse cardiomyocytes, several voltage-dependent K+ channels contribute to outward repolarizing currents, including Kv4.3/4.2 and Kv1.5, which are also present in the human myocardium. Kv1.5 is mainly expressed in the atria [35]. We compared K+ currents in WT and Mib Mib1flox;Tnnt2Cre cardiomyocytes using 500-ms pulses from -80 and +50 mV (Fig 6A). In Mib1flox;Tnnt2Cre cardiomyocytes showed smaller peak transient and sustained currents compared to WT. Density-voltage curves revealed significant reductions in peak current density at potentials ≥−10 mV (Fig 6B) and sustained current at potentials ≥−20 mV (Fig 6C), with a 45.4% reduction in sustained current density +50 mV, and a 25% reduction in peak current density at this voltage (P<0.05). The decay of outward K+ current was faster in Mib1flox;Tnnt2Cre cardiomyocytes (Fig 6A, inset), with a significantly reduced time constant (Fig 6D, Table 4). To further characterize outward K+ currents in Mib1flox;Tnnt2Cre cardiomyocytes, we measured the charge (the total amount of K+ crossing the membrane) during the 500-ms pulses by integrating the current traces to calculate the area. The charge density at potentials ≥-20 mV was significantly lower in Mib1flox;Tnnt2Cre cardiomyocytes (Fig 6E). However, the inward rectifier current (IK1) density and kinetics were similar between WT and Mib1flox;Tnnt2Cre cardiomyocytes (S5 Fig).
+ currents. (A) Outward K+ current traces from WT and Mib1flox;Tnnt2Cre cardiomyocytes, with inset highlighting normalized current traces at +50 mV. (B and C) Current density-voltage relationships at peak (B) and end (C) of pulses in both genotypes. (D) Time constants (τinact) of current decay at +50 mV. Each point represents an experiment. (E) Mean outward K+ charge density-voltage relationships. Statistical significance (*P<0.05 vs WT) was determined using unpaired two-tailed Student’s t-test, adjusting for repeated measures with multilevel mixed-effects models. Data in panels B to E, represent mean±SEM of 21 WT and 30 Mib1flox;Tnnt2Cre cardiomyocytes from five mice per genotype.
Impaired ion channel expression in Mib1flox;Tnnt2Cre mice
To determine whether the electrophysiological abnormalities in Mib1flox;Tnnt2Cre mice were due to defective ion channel expression, we performed immunofluorescence staining and western blot assays for NaV1.5, KV4.2, and KV4.3 in freshly isolated cardiomyocytes and protein extracts obtained from homogenized cardiac tissue, respectively (Fig 7). NaV1.5 expression showed no difference between genotypes in integrated density (Fig 7A,B), but protein levels were increased (Fig.7C,D). Mib1flox;Tnnt2-Cre cardiomyocytes had lower integrated densities for KV4.2 (Fig 7E,F) and KV4.3 (Fig 7I,J), though protein were not significantly different from WT (Fig 7G,H,K,L). These decreases in KV4.2 and KV4.3 density likely contribute to the reduced outward K+ currents and increased APD in Mib1flox;Tnnt2Cre mice.
(A) Immunofluorescence staining of α-actinin (green) and Nav1.5 (red) in WT and Mib1flox;Tnnt2Cre mice, with merged images showing colocalization. Nuclei were stained with DAPI (blue). (B) Quantification of integrated fluorescence intensity (a.u.) from 6 WT and 6 Mib1flox;Tnnt2Cre cardiomyocytes (ns: not significant). (C) Representative Western blot of Nav1.5 and GAPDH. (D) Quantification of protein expression from 5 WT and 6 Mib1flox;Tnnt2Cre mice, showing increased expression in Mib1flox;Tnnt2Cre mice (**P < 0.01 vs WT). (E) Staining for α-actinin (green) and Kv4.2 (red) with merged images indicating colocalization. (F) Quantification of fluorescence intensity from 15 WT and 17 Mib1flox;Tnnt2Cre cardiomyocytes, showing reduced intensity in Mib1flox;Tnnt2Cre mice (***P < 0.001 vs WT). (G) Representative Western blot of Kv4.2 and GAPDH. (H) Quantification of protein expression from 6 WT and 6 Mib1flox;Tnnt2Cre mice (ns: not significant). (I) Staining for α-actinin (green) and Kv4.3 (red), with merged images highlighting colocalization. (J) Quantification of fluorescence intensity from 6 WT and 10 Mib1flox;Tnnt2Cre cardiomyocytes, showing reduced intensity in Mib1flox;Tnnt2Cre mice (**P < 0.01 vs WT). (K) Representative Western blot of Kv4.3 and GAPDH. (L) Quantification of protein expression from 6 WT and 6 Mib1flox;Tnnt2Cre mice, showing increased expression in Mib1flox;Tnnt2Cre mice (ns: not significant). Statistical significance was determined using unpaired two-tailed Student’s t-test. For immunofluorescence, data represent mean±SD of cells from 3-4 animals per genotype. For Western blot, data represent mean±SD of hearts segments from 5-6 animals per genotype.
Abnormal Connexin-43 localization in the hearts of Mib1flox;Tnnt2Cre mice
The gap-junction protein Connexin-43 (CX43) is crucial for electrical excitation in cardiomyocytes [36] and requires N-Cadherin for proper localization at intercalated disks [37]. N-Cadherin and CX43 immunofluorescence analysis (Fig 8A-D) showed significant mislocalization of CX43 to the lateral sides of cardiomyocytes in Mib1flox;Tnnt2Cre hearts (Fig 8E-F’) with reduced CX43 staining associated with N-cadherin (Fig 8A-G). Additionally, immunofluorescence analysis using WGA and Cx43 (Fig 8H–K) confirms the lateralization of Cx43 in Mib1flox;Tnnt2Cre cardiomyocytes (Fig 8L, M). This is demonstrated by an increased ratio of the lateralized Cx43 area to the Cx43 area at the intercalated discs (Fig8N)Cardiac fibrosis, a potential cause of electrical abnormalities [38], was assessed with Picrosirius red staining, but no significant differences were found between groups, either at baseline or after endurance training and isoproterenol treatment (S6 Fig and Fig 6).
(A, B) N-Cadh expression (green) at intercalated disks in WT and Mib1flox;Tnnt2Cre cardiomyocytes. (C) CX43 localization (red) at intercalated disks and lateral membranes in WT cardiomyocytes. (D) CX43 expression is concentrated at the lateral membrane in Mib1flox;Tnnt2Cre cardiomyocytes. (E,F) Merged images with DAPI-stained nuclei (blue); arrowheads highlight predominant CX43 expression in WT (E’) and Mib1flox;Tnnt2boldstart (F’) cardiomyocytes. (G) Quantification of CX43/N-Cadh overlay at intercalated disks using automated image segmentation expressed in percentage. (H, I) WGA (green) plasma membrane labeling in WT and Mib1flox;Tnnt2Cre cardiomyocytes. (J) CX43 localization (red) at intercalated disks and lateral membranes in WT cardiomyocytes. (K) CX43 expression is concentrated at the lateral membrane in Mib1flox;Tnnt2Cre cardiomyocytes. (L,M) Merged images with DAPI-stained nuclei (blue); arrowheads highlight predominant CX43 expression in WT (L’) and Mib1flox;Tnnt2Cre (M’) cardiomyocytes. (N) Ratio of the area occupied by the Cx43 signal on the lateral membrane (outside the ICD) to the area occupied by the signal within the ICD. Statistical significance (*P < 0.05 vs WT) was determined using unpaired two-tailed Student’s t-test. Data represent mean±SD of sections from three animals per genotype, totaling 8-9 sections.
Discussion
MIB1 is an E3 ubiquitin ligase regulating NOTCH ligands endocytosis [23]. Conditional Mib1 inactivation in mouse hearts produces an LVNC phenotype [22]. Our study investigated electrical defects in adult mice with Mib1 inactivation, revealing significant cardiac electrical abnormalities and related molecular, cellular, tissue, and organ changes. Mib1flox;Tnnt2Cre cardiomyocytes showed reduced Kv4.2 and Kv4.3 ion channel expression, increased peak INa density, reduced outward K+ currents densities, and prolonged APD. Under cardiac stress from isoproterenol or swimming, these mice exhibited prolonged QTc duration and decreased T-wave amplitude and area. Patients with MIB1 mutations showed similar prolonged QTc duration and increased QT variability.
LVNC often features abnormal ECG patterns, such as intraventricular conduction delays, left ventricular hypertrophy, left axis deviation, repolarization abnormalities, and QTc prolongation [27]. In mice with LVNC resulting from Nkx2–5 inactivation, defects include a widened QRS interval and reduced R amplitude, but no changes in QT interval or T wave amplitude [13]. In our study, Mib1flox;Tnnt2Cre mice showed no significant changes in basal cardiac electrical activity but tended towards a lengthened PR interval and QTc duration. ECG abnormalities can appear during exercise or with symptoms; one LVNC patient had exercise-induced atrial and ventricular tachycardia [39]. Swimming endurance caused a ~2 ms increase in QRS interval and ~8.8 ms increase in QTc90 duration in Mib1flox;Tnnt2Cre mice. Isoproterenol-induced stress increased QTc90 duration by ~5.8 ms. Prolonged QT interval raises the risk of ventricular arrhythmia and sudden cardiac death [40]. Four Mib1flox;Tnnt2Cre mice died during the swimming protocol, likely due to ventricular repolarization abnormalities. Mib1flox;Tnnt2Cre mutants have reduced ejection fraction and impaired coronary vessel formation [22], triggering ventricular ischemia. Hypoxia in adult patients is linked to prolonged QT interval and arrhythmias [41]. Neonatal mice with oxygen deprivation or increased hypoxia-inducible factor signaling showed prolonged QTc, increased QTc dispersion, disturbed ion channel expression, and higher sudden death risk [42]. During exercise, hypoxia is associated with lower P-wave, QRS complex, and T-wave amplitudes [43].
The T-wave in the ECG indicates ventricular repolarization, with alterations like increased duration, low amplitude, and inversion. In Mib1flox;Tnnt2Cre mice, post-swimming T-wave analysis showed low amplitude and area, indicating ventricular repolarization abnormalities. These may result from low KV4.2 and KV4.3 ion channel density, reduced outward K+ current, and increased AP duration. Low transient outward K+ current and Kv4.3 mRNA expression are linked to low T-wave amplitude in long-term cardiac memory models [44].
Cardiac APD is regulated by depolarizing currents (mainly INa and ICa,L) and hyperpolarizing currents (transient outward K+, delayed rectifier, and IK1 currents) [45]. INa controls rapid depolarization of cardiomyocytes, and INaL regulates action potential duration [46]. Our results showed a significant increase in peak INa and Nav1.5 expression in Mib1flox;Tnnt2Cre cardiomyocytes. Persistent PKA activation promotes Nav1.5 trafficking to the cytoplasmic membrane, especially at intercalated discs [47]. This increase in INa could be due to persistent β-adrenoceptor stimulation from cardiac stress. However, this did not enhance intracardiac conduction; instead, the QRS interval was widened in both LVNC patients and Mib1flox;Tnnt2Cre mice post-swimming.
Gap junction proteins, essential for intercellular electrical coupling, are mainly located at intercalated disks [48]. CX43 is the primary connexin in ventricles, and its impaired function is linked to many cardiomyopathies [49]. In Mib1flox;Tnnt2Cre cardiomyocytes, CX43 was mostly located laterally, unlike its typical position at intercalated discs in WT cells. While we did not analyze the total Cx43 expression levels, its mislocalization suggests impaired gap junction organization, which can slow conduction velocity and increase susceptibility to arrhythmias. Additionally, Cx43 function is tightly regulated by phosphorylation at multiple serine residues, affecting gap junction assembly, degradation, and electrical coupling [50], overshadowing the increased INa and explaining the conduction defects in Mib1flox;Tnnt2Cre mice and LVNC patients. Although our study did not assess Cx43 phosphorylation status, altered phosphorylation could contribute to the observed lateralization and functional impairment, warranting further investigation. Similar findings were reported in a recent LVNC model with ROCK signaling disruption, where Cx43 was also mislocalized, conduction velocity was reduced, and increased fibrosis was observed [51]. While fibrosis in Mib1flox;Tnnt2Cre mice was not a prominent feature, both models suggest that electrical uncoupling due to Cx43 abnormalities may play a central role in LVNC pathophysiology.
Cell hypertrophy is another important factor affecting impulse propagation. Mib1flox;Tnnt2Cre cardiomyocytes exhibited hypertrophy, as observed through WGA staining and conductance measurements, which could further contribute to slowing conduction. Larger cell size increases cell capacitance and cytoplasmic resistance, potentially exacerbating delays in impulse propagation and leading to the widened QRS interval observed post-swimming. In contrast, the ROCKDN transgenic mouse model showed more pronounced fibrosis, which can also disrupt electrical continuity and slow conduction [51]. These differences highlight the heterogeneity of LVNC pathophysiology and suggest that conduction abnormalities may arise from multiple factors, including Cx43 mis localization, altered phosphorylation, hypertrophy, and extracellular matrix remodeling.
Studies on ICa,L in heart failure have reported conflicting results [52,53]. After normalizing for cell capacitance, we found no significant differences in peak ICa,L density or inactivation kinetics between genotypes. However, in Mib1flox;Tnnt2Cre cardiomyocytes, the inactivation-curve midpoint was slightly shifted to more depolarized potentials. Thus, the prolonged APD in Mib1flox;Tnnt2Cre cardiomyocytes is likely due to changes in currents other than L-type Ca2+ channels.
A decrease in outward K+ current prolongs the APD and QT interval [54]. Mib1flox;Tnnt2Cre mice had significantly reduced peak and sustained outward K+ currents, closely associated with increased APD20, APD50, and APD90. Kv4.3/4.2 channel expression was significantly reduced, leading to lower transient outward K+ current, increased Ca2+ influx, and higher intracellular calcium concentration, enhancing CaMKII activity [35]. This activates CaMKII and calcineurin, triggering hypertrophic gene activation as a compensatory response, but sustained hypertrophy risks progressing to heart failure and cardiomyopathy [55]. Although our findings provide insight into the electrophysiological alterations associated with LVNC, it is crucial to acknowledge intrinsic differences between murine and human cardiac repolarization, which limit the direct extrapolation of our data. Unfortunately, cardiac repolarization in mouse and human hearts exhibits important differences, a disadvantage that is counterbalanced by the benefits of using mouse models to reproduce human diseases [56]. In mice, peak and sustained outward K+ currents are primarily generated by Kv4.3/4.2 and Kv1.5 channels, which play a major role in human atrial repolarization [35]. However, the presence of rapid and slow delayed rectifier K+ currents (IKr and IKs), which critically regulate human ventricular repolarization, appears to be negligible in mouse cardiomyocytes [35]. Furthermore, in human cardiomyocytes, isoproterenol increases ICaL and IKs, decreases peak, and has no effect on sustained outward K+ currents [57]. Therefore, while the effects of isoproterenol on AP duration may appear similar in murine and human ventricles, the underlying mechanisms are likely to differ.
QT variability measures spontaneous fluctuations in QT interval duration [58] and is an indicator of ventricular arrhythmias and sudden cardiac death. Increased QT variability is linked to coronary artery disease and left ventricular hypertrophy [59]. While QT variability was not increased in Mib1flox;Tnnt2Cre mice, it was elevated in LVNC patients with MIB1 mutations, suggesting a higher risk of ventricular arrhythmias. Other features of Mib1flox;Tnnt2Cre mice, such as a long QTc, were also present in LVNC patients with MIB1 mutations.
Summary and Conclusions
Mib1flox;Tnnt2Cre mice exhibit prolonged QTc duration and decreased T-wave amplitude and area under swimming endurance exercise or isoproterenol-induced stress. Freshly isolated Mib1flox;Tnnt2Cre cardiomyocytes showed increased INa, decreased outward K+ currents, prolonged APD, reduced Kv4.2 and KV4.3 expression, and lateral redistribution of CX43, which may contribute to conduction defects. Although these findings provide valuable insights into the electrical disturbances associated with MIB1 deficiency, the extrapolation to human pathophysiology requires caution due to species-specific differences in cardiac repolarization mechanisms. Nevertheless, the presence of prolonged QTc and increased QT variability in LVNC patients with MIB1 mutations suggests that the electrical remodeling observed in Mib1flox;Tnnt2Cre mice may have clinical relevance. Further studies in human models are necessary to determine the precise impact of these alterations on arrhythmogenesis and disease progression.
Supporting information
S1 Fig. Electrocardiographic recordings from patients carrying MIB1 mutations and healthy relatives.
(A) Original ECG recordings from 4 individuals presenting MIB1VF943F (2 individuals) and MIB1R530X mutations (2 individuals). (B) Original ECG recordings from 4 healthy relatives.
https://doi.org/10.1371/journal.pone.0314840.s001
(TIF)
S2 Fig. Blood Pressure analysis.
Averaged systolic pressure (A) and diastolic pressure (B) of WT and Mib1flox;Tnnt2Cre mice did not show differences between groups neither before and after swimming endurance training. Statistical significance was determined by ANOVA followed by the Tukey post-hoc test for multiple comparisons. Results are expressed as mean±SD of 7–6 WT and 9–5 Mib1flox;Tnnt2Cre mice. (C) Ratio Heart Weight/Tibia. Summary data showing no differences between WT and Mib1flox;Tnnt2Cre mice. Statistical significance was determined by unpaired two-tailed Student’s t-test. Results are expressed as mean±SD of 15 WT and 15 Mib1flox;Tnnt2Cre mice. (D) Homogeneity of training intensity. Analysis of the distance swum determined from consecutive time-lapse images for 1 min video recorded (online video 1 and 2, the dots and lines represent each animal and lines represent the tracking of a single animal.). The data is adjusted to a Gaussian pattern (passed the D’Agostino & Pearson normality test, alpha = 0.05). (E) Survival curve of mice during endurance training. Analysis of WT and Mib1flox;Tnnt2Cre mice survival percentage during the endurance swimming.
https://doi.org/10.1371/journal.pone.0314840.s002
(TIF)
S3 Fig. Wheat germ agglutinin (WGA) staining in mouse heart sections.
(A) Representative confocal image of myocardial sections exhibiting increased cardiomyocyte size in the Mib1flox;Tnnt2Cre mice. (B) Summary data showing that cardiomyocytes area (µm2)/ tibial (mm) ratio is increased in Mib1flox;Tnnt2Cre mice. (C) Summary data showing that cardiomyocyte capacitance is increased in Mib1flox;Tnnt2Cre mice. Statistical significance was determined by unpaired two-tailed Student’s t-test. To take into account repeated sample assessments, data were analysed with multilevel mixed-effects models. **P < 0.01; ****P < 0.0001 vs WT. In B, results are expressed as mean±SD of 400–600 cells from 3 animals per genotype. In C results are expressed as mean±SEM of 55–60 cells from 5 animals per genotype.
https://doi.org/10.1371/journal.pone.0314840.s003
(TIF)
S4 Fig. Mib1 inactivation did not modify INa recovery from inactivation or the INaL.
(A) Time course of peak INa recovery from inactivation measured by using a double-pulse protocol (see supplementary methods) in WT and Mib1flox;Tnnt2Cre mice. Continuous lines represent the fit of a monoexponential function to the data. Each point represents the mean±SEM of n experiments/cells. (B) INaL (expressed as percentage of the peak current) recorded at the end of 500-ms pulses to -40 mV from a holding potential of -120 mV. Unpaired two-tailed Student’s t-test was used. Statistical significance was confirmed by using non-parametric tests (two-sided Wilcoxon’s test) for small-size samples (n<15). To take into account repeated sample assessments, data were analyzed with multilevel mixed-effects models. Each bar represents the mean±SEM of 10 WT and 6 Mib1flox;Tnnt2Cre cardiomyocytes dissociated from 5 animals per genotype.
https://doi.org/10.1371/journal.pone.0314840.s004
(TIF)
S5 Fig. Effects of Mib1 inactivation on K+ currents.
(A) Representative IK1 traces recorded in two cardiomyocytes from WT or Mib1flox;Tnnt2Cre mice by applying the pulse protocol shown at the top. (B) Mean current density-voltage curves for IK1 recorded in cardiomyocytes from both mouse groups. Unpaired two-tailed Student’s t-test was used. Statistical significance was confirmed by using non-parametric tests (two-sided Wilcoxon’s test) for small-size samples (n<15). To take into account repeated sample assessments, data were analysed with multilevel mixed-effects models. Results are expressed as mean±SEM of 19 WT and 14 Mib1flox;Tnnt2Cre cardiomyocytes dissociated from 5 animals per genotype.
https://doi.org/10.1371/journal.pone.0314840.s005
(TIF)
S6 Fig. Picrosirius red of collagen staining in mouse heart sections.
Picrosirius red observed under bright field microscopy in WT (A) and Mib1flox;Tnnt2Cre (C) heart section did not exhibit myocardial fibrosis. (a’, a,” a”’) close-up views of the LV, RV, and septum of the WT heart section. (c’, c,” c”’) close-up views of the LV, RV, and septum of the Mib1flox;Tnnt2Cre heart section. (B and D) Quantification of the areas occupied by picrosirius-positive collagen in WT and Mib1flox;Tnnt2Cre mice after endurance swimming (B) and isoproterenol (D) protocol. Statistical significance was determined by ANOVA followed by the Tukey post-hoc test for multiple comparisons. In B and D, each point represents the mean of 3 section per animal. Results are expressed as mean±SD of 5–7 WT and 6–9 Mib1flox;Tnnt2Cre mice.
https://doi.org/10.1371/journal.pone.0314840.s006
(TIF)
S1 Video Legend. Video showing WT and Mib1flox;Tnnt2Cre mice swimming.
https://doi.org/10.1371/journal.pone.0314840.s007
(MP4)
S2 Video Legend. Video tracing WT and Mib1flox;Tnnt2Cre mice when swimming.
https://doi.org/10.1371/journal.pone.0314840.s008
(MPG)
References
- 1. Oechslin E, Jenni R. Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?. Eur Heart J. 2011;32(12):1446–56. pmid:21285074
- 2. Gati S, Papadakis M, Papamichael ND, Zaidi A, Sheikh N, Reed M, et al. Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations. Circulation. 2014;130(6):475–83. pmid:25006201
- 3. Wengrofsky P, Armenia C, Oleszak F, Kupferstein E, Rednam C, Mitre CA, et al. Left Ventricular Trabeculation and Noncompaction Cardiomyopathy: A Review. EC Clin Exp Anat. 2019;2(6):267-83. Epub 20190729. pmid:31799511; PMCID: PMC6890222.
- 4. Duru F, Candinas R. Noncompaction of ventricular myocardium and arrhythmias. J Cardiovasc Electrophysiol. 2000;11(4):493. pmid:10809508
- 5. Ichida F. Left ventricular noncompaction - Risk stratification and genetic consideration. J Cardiol. 2020;75(1):1–9. pmid:31629663
- 6. Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW, et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation. 2003;108(21):2672–8. pmid:14623814
- 7. Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation. 2008;117(22):2893–901. pmid:18506004
- 8. van Waning JI, Caliskan K, Hoedemaekers YM, van Spaendonck-Zwarts KY, Baas AF, Boekholdt SM, et al. Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy. J Am Coll Cardiol. 2018;71(7):711-22. Epub 2018/02/16. PubMed pmid:29447731.
- 9. Ichida F, Tsubata S, Bowles KR, Haneda N, Uese K, Miyawaki T, et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation. 2001;103(9):1256–63. pmid:11238270
- 10. Grego-Bessa J, Luna-Zurita L, del Monte G, Bolós V, Melgar P, Arandilla A, et al. Notch signaling is essential for ventricular chamber development. Dev Cell. 2007;12(3):415–29. pmid:17336907
- 11. Sedaghat-Hamedani F, Haas J, Zhu F, Geier C, Kayvanpour E, Liss M, et al. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy. Eur Heart J. 2017;38(46):3449–60. pmid:29029073
- 12. Zhang W, Chen H, Qu X, Chang C-P, Shou W. Molecular mechanism of ventricular trabeculation/compaction and the pathogenesis of the left ventricular noncompaction cardiomyopathy (LVNC). Am J Med Genet C Semin Med Genet. 2013;163C(3):144–56. pmid:23843320
- 13. Choquet C, Nguyen THM, Sicard P, Buttigieg E, Tran TT, Kober F, et al. Deletion of Nkx2-5 in trabecular myocardium reveals the developmental origins of pathological heterogeneity associated with ventricular non-compaction cardiomyopathy. PLoS Genet. 2018;14(7):e1007502. pmid:29979676
- 14. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284(5415):770–6. pmid:10221902
- 15. Kopan R. Notch signaling. Cold Spring Harb Perspect Biol. 2012;4(10):a011213. pmid:23028119
- 16. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437(7056):270–4. pmid:16025100
- 17. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707–10. pmid:8878478
- 18. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. 1997;16(3):243–51. pmid:9207788
- 19. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet. 1997;16(3):235–42. pmid:9207787
- 20. MacGrogan D, Münch J, de la Pompa JL. Notch and interacting signalling pathways in cardiac development, disease, and regeneration. Nat Rev Cardiol. 2018;15(11):685–704. pmid:30287945
- 21. Meester JAN, Verstraeten A, Alaerts M, Schepers D, Van Laer L, Loeys BL. Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. Clin Genet. 2019;95(1):85–94. pmid:29767458
- 22. Luxán G, Casanova JC, Martínez-Poveda B, Prados B, D’Amato G, MacGrogan D, et al. Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nat Med. 2013;19(2):193–201. pmid:23314057
- 23. Itoh M, Kim C-H, Palardy G, Oda T, Jiang Y-J, Maust D, et al. Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell. 2003;4(1):67–82. pmid:12530964
- 24. D’Amato G, Luxán G, del Monte-Nieto G, Martínez-Poveda B, Torroja C, Walter W, et al. Sequential Notch activation regulates ventricular chamber development. Nat Cell Biol. 2016;18(1):7–20. pmid:26641715
- 25. Siguero-Álvarez M, Salguero-Jiménez A, Grego-Bessa J, de la Barrera J, MacGrogan D, Prados B, et al. A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve. Circulation. 2023;147(1):47–65. pmid:36325906
- 26. Steffel J, Kobza R, Oechslin E, Jenni R, Duru F. Electrocardiographic characteristics at initial diagnosis in patients with isolated left ventricular noncompaction. Am J Cardiol. 2009;104(7):984–9. pmid:19766768
- 27. Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomyopathy. Lancet. 2015;386(9995):813–25. pmid:25865865
- 28. Rivera-Torres J, Calvo CJ, Llach A, Guzmán-Martínez G, Caballero R, González-Gómez C, et al. Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations. Proc Natl Acad Sci U S A. 2016;113(46):E7250–9. pmid:27799555
- 29. Mitchell GF, Jeron A, Koren G. Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol. 1998;274(3):H747-51. pmid:9530184
- 30. Cruz FM, Sanz-Rosa D, Roche-Molina M, García-Prieto J, García-Ruiz JM, Pizarro G, et al. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. J Am Coll Cardiol. 2015;65(14):1438–50. pmid:25857910
- 31. Puhl S-L, Weeks KL, Ranieri A, Avkiran M. Assessing structural and functional responses of murine hearts to acute and sustained β-adrenergic stimulation in vivo. J Pharmacol Toxicol Methods. 2016;79:60–71. pmid:26836145
- 32. Caballero R, Utrilla RG, Amorós I, Matamoros M, Pérez-Hernández M, Tinaquero D, et al. Tbx20 controls the expression of the KCNH2 gene and of hERG channels. Proc Natl Acad Sci U S A. 2017;114(3):E416–25. pmid:28049825
- 33. Nieto-Marín P, Tinaquero D, Utrilla RG, Cebrián J, González-Guerra A, Crespo-García T, et al. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome. Cardiovasc Res. 2022;118(4):1046–60. pmid:33576403
- 34. Le Page S, Niro M, Fauconnier J, Cellier L, Tamareille S, Gharib A, et al. Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1+/- Mouse Model. PLoS One. 2016;11(10):e0164066. pmid:27723783
- 35. Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev. 2005;85(4):1205–53. pmid:16183911
- 36. Beauchamp P, Desplantez T, McCain ML, Li W, Asimaki A, Rigoli G, et al. Electrical coupling and propagation in engineered ventricular myocardium with heterogeneous expression of connexin43. Circ Res. 2012;110(11):1445–53. pmid:22518032
- 37. Matsuda T, Fujio Y, Nariai T, Ito T, Yamane M, Takatani T, et al. N-cadherin signals through Rac1 determine the localization of connexin 43 in cardiac myocytes. J Mol Cell Cardiol. 2006;40(4):495–502. pmid:16515795
- 38. Nguyen TP, Qu Z, Weiss JN. Cardiac fibrosis and arrhythmogenesis: the road to repair is paved with perils. J Mol Cell Cardiol. 2014;70:83–91. pmid:24184999
- 39. Seethala S, Knollman F, McNamara D, Saba S, Schwender F, Schwartzman D, et al. Exercise-induced atrial and ventricular tachycardias in a patient with left ventricular noncompaction and normal ejection fraction. Pacing Clin Electrophysiol. 2011;34(10):e94-7. pmid:20565692
- 40. Postema PG, Wilde AAM. The measurement of the QT interval. Curr Cardiol Rev. 2014;10(3):287–94. pmid:24827793
- 41. Roche F, Reynaud C, Pichot V, Duverney D, Costes F, Garet M, et al. Effect of acute hypoxia on QT rate dependence and corrected QT interval in healthy subjects. Am J Cardiol. 2003;91(7):916–9. pmid:12667592
- 42. Neary MT, Mohun TJ, Breckenridge RA. A mouse model to study the link between hypoxia, long QT interval and sudden infant death syndrome. Dis Model Mech. 2013;6(2):503–7. pmid:22977222
- 43. Coustet B, Lhuissier FJ, Vincent R, Richalet J-P. Electrocardiographic changes during exercise in acute hypoxia and susceptibility to severe high-altitude illnesses. Circulation. 2015;131(9):786–94. pmid:25561515
- 44. Yu H, McKinnon D, Dixon JE, Gao J, Wymore R, Cohen IS, et al. Transient outward current, Ito1, is altered in cardiac memory. Circulation. 1999;99(14):1898–905. pmid:10199889
- 45. Wickenden AD, Kaprielian R, Kassiri Z, Tsoporis JN, Tsushima R, Fishman GI, et al. The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res. 1998;37(2):312–23. pmid:9614488
- 46. Ke H-Y, Yang H-Y, Francis AJ, Collins TP, Surendran H, Alvarez-Laviada A, et al. Changes in cellular Ca2+ and Na+ regulation during the progression towards heart failure in the guinea pig. J Physiol. 2020;598(7):1339–59. pmid:30811606
- 47. Bernas T, Seo J, Wilson ZT, Tan B-H, Deschenes I, Carter C, et al. Persistent PKA activation redistributes NaV1.5 to the cell surface of adult rat ventricular myocytes. J Gen Physiol. 2024;156(2):e202313436. pmid:38226948
- 48. Vaidya D, Tamaddon HS, Lo CW, Taffet SM, Delmar M, Morley GE, et al. Null mutation of connexin43 causes slow propagation of ventricular activation in the late stages of mouse embryonic development. Circ Res. 2001;88(11):1196–202. pmid:11397787
- 49. Seidel T, Salameh A, Dhein S. A simulation study of cellular hypertrophy and connexin lateralization in cardiac tissue. Biophys J. 2010;99(9):2821–30. pmid:21044579
- 50. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res. 2001;88(3):333–9. pmid:11179202
- 51. Sedmera D, Olejnickova V, Sankova B, Kolesova H, Bartos M, Kvasilova A, et al. Morphological, electrophysiological, and molecular alterations in foetal noncompacted cardiomyopathy induced by disruption of ROCK signalling. Front Cell Dev Biol. 2024;12:1471751. pmid:39435333
- 52. Beuckelmann DJ, Näbauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85(3):1046–55. pmid:1311223
- 53. Qin D, Zhang ZH, Caref EB, Boutjdir M, Jain P, el-Sherif N. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ Res. 1996;79(3):461–73. pmid:8781480
- 54. Qu Z, Chung D. Mechanisms and determinants of ultralong action potential duration and slow rate-dependence in cardiac myocytes. PLoS One. 2012;7(8):e43587. pmid:22952713
- 55. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93(2):215–28. pmid:9568714
- 56. Rydell-Törmänen K, Johnson JR. The Applicability of Mouse Models to the Study of Human Disease. Methods Mol Biol. 2019;1940:3–22. pmid:30788814
- 57. González de la Fuente M, Barana A, Gómez R, Amorós I, Dolz-Gaitón P, Sacristán S, et al. Chronic atrial fibrillation up-regulates β1-Adrenoceptors affecting repolarizing currents and action potential duration. Cardiovasc Res. 2013;97(2):379–88. pmid:23060133
- 58. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation. 1997;96(5):1557–65. pmid:9315547
- 59. Schlegel TT, Kulecz WB, Feiveson AH, Greco EC, DePalma JL, Starc V, et al. Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction. BMC Cardiovasc Disord. 2010;10:28. pmid:20565702